Ameren (NYSE:AEE) has received mixed analyst ratings over the past three months, with a recent shift towards more positive evaluations. Analysts have updated their price targets, reflecting an average increase to $75.83, up from $74.80. This change is based on Ameren's solid financial performance, including a 12.24% revenue growth and a net margin of 14.37%, despite its market capitalization and returns on equity and assets being below industry benchmarks. The company's debt management is noted as balanced, with a debt-to-equity ratio of 1.5.